Clinical readiness of AI in early gastric cancer: A call for real-world validation and equitable implementation.
APA
Lu Y, Hu Y, He Y (2026). Clinical readiness of AI in early gastric cancer: A call for real-world validation and equitable implementation.. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 58(4), 573-574. https://doi.org/10.1016/j.dld.2025.11.018
MLA
Lu Y, et al.. "Clinical readiness of AI in early gastric cancer: A call for real-world validation and equitable implementation.." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, vol. 58, no. 4, 2026, pp. 573-574.
PMID
41692644
같은 제1저자의 인용 많은 논문 (5)
- Emerging epidemiological trends in primary cutaneous lymphomas: a population-based analysis.
- Immune checkpoint inhibitor-related efficacy in non-small cell lung cancer: real-world incidence and management practices of 208 patients.
- Optimized hookworm-derived biologic, AIP-2 restores mucosal tolerance and down-regulates colon cancer-associated gene expression in TNBS-induced colitis.
- Microbiota-host interaction in colorectal cancer: emerging computational technology, multi-omics integration, and mechanisms.
- Mitochondrial uncoupling sensitizes gastric cancer cells to elesclomol-induced cuproptosis via FDX1/DLAT upregulation.